PD98059
目录号:S1177 Purity: 99.92%
PD98059 是一种非ATP竞争性的MEK抑制剂,无细胞试验中IC50为2 μM,特异性抑制MEK-1介导的MAPK激活;不直接抑制ERK1或ERK2。PD98059 是一种aryl hydrocarbon receptor (AHR)的配体并起到拮抗剂的功能。
CAS: 167869-21-8
客户使用Selleck的PD98059发表文献501篇
- Cancer Discov, 2022 candisc.1672.2021
- Signal Transduct Target Ther, 2021 6(1):333
- Immunity, 2021 S1074-7613(20)30538-0
- Cancer Cell, 2019 35(1):17-32
- Cancer Cell, 2019 35(5):798-815.e5
- Am J Respir Crit Care Med, 2019 200(5):617-627
- Cancer Cell, 2017 32(6):840-855
- Cell Stem Cell, 2017 20(3):329-344
- Nature, 2016 10.1038/nature19347
- Cell Mol Immunol, 2016 13(4):524-34
- Cell Mol Immunol, 2016 13(5):640-50
- Cancer Cell, 2015
- Cancer Cell, 2014 26(5):754-69
- Nat Commun, 2024 15(1):987
- Adv Sci (Weinh), 2024 11(4):e2304987
- Exp Mol Med, 2024 56(12):2602-2616
- Cell Commun Signal, 2024 22(1):473
- EMBO Rep, 2024 10.1038/s44319-024-00324-1
- Biochim Biophys Acta Mol Basis Dis, 2024 1870(7):167286
- Stem Cell Reports, 2024 19(7):973-992
- iScience, 2024 27(10):111049
- iScience, 2024 27(6):110029
- Cancer Cell Int, 2024 24(1):54
- J Virol, 2024 e0068524.
- Front Mol Neurosci, 2024 17:1371145
- Sci Rep, 2024 14(1):29647
- Microorganisms, 2024 12(1)188
- Acta Biochim Biophys Sin (Shanghai), 2024 56(7):1072-1084
- PLoS One, 2024 19(11):e0313560
- Front Cardiovasc Med, 2024 11:1410862
- Hematology, 2024 29(1):2356292
- J Biomed Res, 2024 38(4):382-396
- bioRxiv, 2024 2024.08.30.610360
- Bioact Mater, 2023 21:403-421
- Adv Sci (Weinh), 2023 10(25):e2302747
- J Exp Clin Cancer Res, 2023 42(1):25
- Cell Death Dis, 2023 14(8):557
- Cell Prolif, 2023 e13551.
- Vaccines (Basel), 2023 10.3390/vaccines11101576
- Ecotoxicol Environ Saf, 2023 260:115089
- Mol Med, 2023 29(1):88
- Cancer Sci, 2023 114(6):2622-2633
- Int J Mol Sci, 2023 10.3390/ijms242015151
- Exp Neurol, 2023 359:114265
- Burns Trauma, 2023 11:tkad020
- Biomedicines, 2023 12(1)36
- Mediators Inflamm, 2023 2023:2364121
- Cancer Biol Ther, 2023 24(1):2206362
- Dev Comp Immunol, 2023 139:104555
- BMC Womens Health, 2023 23(1):15
- J Ophthalmol, 2023 2023:7355039
- Zoonoses, 2023 10.15212/ZOONOSES-2022-0045
- Nat Commun, 2022 13(1):3706
- EBioMedicine, 2022 85:104274
- Cancer Lett, 2022 541:215749
- Int J Biol Sci, 2022 18(10):3918-3933
- Cell Death Dis, 2022 13(7):626
- Cell Rep, 2022 40(7):111206
- Biomed Pharmacother, 2022 150:112964
- Biomed Pharmacother, 2022 145:112437
- Front Immunol, 2022 13:984520
- Biomater Sci, 2022 10(20):5938-5946
- Cells, 2022 11(1)134
- Nutrients, 2022 14(18)3721
- iScience, 2022 25(10):105182
- Open Biol, 2022 12(10):220213
- Cancer Immunol Immunother, 2022 10.1007/s00262-021-03126-9
- Front Pharmacol, 2022 13:911157
- Front Pharmacol, 2022 13:817596
- Front Pharmacol, 2022 13:823975
- J Ethnopharmacol, 2022 S0378-8741(22)00252-5
- Oncotarget, 2022 13:944-959
- Mol Nutr Food Res, 2022 e2200186
- Cancers (Basel), 2022 14(2)278
- Front Endocrinol (Lausanne), 2022 13:873727
- J Inflamm (Lond, 2022 19(1:26)
- Front Mol Biosci, 2022 9:983410
- Neuropathol Appl Neurobiol, 2022 e12795
- FASEB J, 2022 36(5):e22292
- FASEB J, 2022 36(8):e22427
- Front Mol Neurosci, 2022 15:881933
- Microorganisms, 2022 10(10)1996
- J Diabetes Res, 2022 2022:4067812
- J Pain, 2022 S1526-5900(22)00365-0
- Biol Trace Elem Res, 2022 10.1007/s12011-022-03169-8
- BMC Cancer, 2022 22(1):864
- Microbiol Spectr, 2022 e0188121
- J Cancer Res Clin Oncol, 2022 1007/s00432-022-04197-6
- Int J Med Sci, 2022 19(12):1724-1731
- J Periodontal Res, 2022 10.1111/jre.12986
- Mol Med Rep, 2022 25(2)56
- Evid Based Complement Alternat Med, 2022 2022:3744618
- Pathol Oncol Res, 2022 28:1610273
- Mol Cell, 2021 S1097-2765(21)00269-0
- J Hazard Mater, 2021 422:126850
- Cell Death Dis, 2021 12(4):344
- Cell Rep, 2021 35(13):109331
- Int J Biol Macromol, 2021 180:129-142
- Oncogene, 2021 10.1038/s41388-021-02097-6
- J Dent Res, 2021 220345211054744
- Oxid Med Cell Longev, 2021 2021:6625517
- Front Immunol, 2021 12:654998
- Front Immunol, 2021 12:737988
- Oncoimmunology, 2021 10(1):1897295
- Ecotoxicol Environ Saf, 2021 214:112080
- Mol Oncol, 2021 10.1002/1878-0261.12936
- J Agric Food Chem, 2021 10.1021/acs.jafc.1c00199
- Food Funct, 2021 12(15):6755-6765
- Cancer Cell Int, 2021 21(1):302
- Biochem Pharmacol, 2021 186:114479
- Int J Pharm, 2021 606:120876
- Front Bioeng Biotechnol, 2021 9:732917
- Int J Mol Sci, 2021 22(9)4652
- Int Immunopharmacol, 2021 97:107628
- Front Pharmacol, 2021 12:731980
- J Cell Physiol, 2021 236(2):1375-1390
- Front Cell Dev Biol, 2021 9:797047
- Front Cell Dev Biol, 2021 9:692028
- Front Cell Dev Biol, 2021 9:694675
- J Ethnopharmacol, 2021 282:114582
- Drug Deliv Transl Res, 2021 10.1007/s13346-021-01065-7
- J Ethnopharmacol, 2021 270:113783
- Int J Mol Med, 2021 47(6)103
- Front Microbiol, 2021 12:713531
- mSphere, 2021 6(1)e00986-20
- J Biol Chem, 2021 S0021-9258(21)00173-3
- Viruses, 2021 13(6)1062
- Front Oncol, 2021 11:621154
- Molecules, 2021 26(8)2204
- J Gastroenterol Hepatol, 2021 10.1111/jgh.15486
- ACS Omega, 2021 6(7):4759-4766
- J Immunol Res, 2021 2021:8483938
- BMC Complement Med Ther, 2021 21(1):128
- Mol Cells, 2021 44(10):710-722
- Int J Med Sci, 2021 18(11):2251-2261
- Front Vet Sci, 2021 8:670949
- Pathol Oncol Res, 2021 27:640936
- J Thorac Dis, 2021 13(10):5996-6011
- BMC Anesthesiol, 2021 21(1):257
- Am J Transl Res, 2021 13(2):708-718
- Genome Biol, 2020 21(1):174
- Part Fibre Toxicol, 2020 17(1):46
- Cell Death Dis, 2020 11(2):143
- Cell Death Dis, 2020 14;11(4):230
- Cell Rep, 2020 7;30(1):215-228 e5
- Chemosphere, 2020 246:125774
- Oncogene, 2020 10.1038/s41388-020-01453-2
- Transl Res, 2020 S1931-5244(20)30250-4
- Biomed Pharmacother, 2020 121:109669
- Biomed Pharmacother, 2020 23;128:110245
- Biomed Pharmacother, 2020 131:110724
- Stem Cell Res Ther, 2020 11(1):28
- Oxid Med Cell Longev, 2020 12;2020:6837982
- Cell Oncol (Dordr), 2020 10.1007/s13402-020-00554-0
- Glia, 2020 10.1002/glia.23790
- Life Sci, 2020 13;252:117666
- Food Funct, 2020 11(12):10968-10978
- Am J Chin Med, 2020 48(1):223-244
- Int J Mol Sci, 2020 16;21(10):E3527
- Int Immunopharmacol, 2020 81:105979
- Int J Mol Sci, 2020 21(4)
- Cancer Biol Med, 2020 17(2):357-370
- J Ethnopharmacol, 2020 S0378-8741(20)33532-7
- Drug Deliv Transl Res, 2020 7
- Am J Cancer Res, 2020 10(11):3765-3783
- J Cell Mol Med, 2020 10.1111/jcmm.15665
- J Cell Mol Med, 2020 10.1111/jcmm.16135
- J Cell Mol Med, 2020 24(8):4480-4493
- Cancers (Basel), 2020 12(10)E2795
- Cancers (Basel), 2020 12(11)E3216
- Chem Biol Interact, 2020 315:108910
- Am J Physiol Endocrinol Metab, 2020 1;318(5):E613-E624
- Eur J Pharmacol, 2020 868:172886
- Endocrinology, 2020 161(12)bqaa190
- FASEB J, 2020 10.1096/fj.202000186RRR
- Am J Physiol Heart Circ Physiol, 2020 10.1152/ajpheart.00606.2020
- J Biol Chem, 2020 295(3):673-689
- Sci Rep, 2020 10(1):13124
- Microorganisms, 2020 8(3)389
- Environ Toxicol, 2020 10.1002/tox.22942
- BMC Microbiol, 2020 20(1):171
- Bone, 2020 141:115573
- Onco Targets Ther, 2020 2;13:2757-2769
- Onco Targets Ther, 2020 13:7165-7176
- Toxicol Sci, 2020 kfaa159
- Oral Dis, 2020 10.1111
- Anim Biotechnol, 2020 1-13
- Cardiovasc Drugs Ther, 2020 10.1007/s10557-020-07117-3
- Exp Biol Med (Maywood), 2020 245(1):21-33
- Exp Biol Med (Maywood), 2020 245(7):654-666
- Biochem Biophys Res Commun, 2020 524(4):1064-1071
- Biochem Biophys Res Commun, 2020 521(2):492-498
- Int J Gen Med, 2020 13:1495-1507
- Am J Transl Res, 2020 12(7):3557-3576
- Curr Eye Res, 2020 10.1080/02713683
- Brain Inj, 2020 34(9):1277-1282
- Sci Adv, 2020 22;6(21):eaaz5913
- Neuroreport, 2020 31(14):1007-1014
- Mol Biomed, 2020 1(1):18
- BioMed Research International, 2019- 10.1155/2019/3851718
- Nat Commun, 2019 10(1-:1128
- Emerg Microbes Infect, 2019 8(1):934-945
- Dev Cell, 2019 51(5):602-616.e12
- EMBO J, 2019 38(12)
- Cancer Res, 2019 10.1158/0008-5472.CAN-19-1555
- Cancer Res, 2019 10.1158/0008-5472.CAN-18-2486
- EBioMedicine, 2019 42:326-339
- Cancer Lett, 2019 10.1016/j.canlet.2019.07.016
- BMC Med, 2019 17(1):42
- Pharmacol Res, 2019 143:73-85
- Int J Biol Sci, 2019 15(8):1685-1695
- Cell Prolif, 2019 52(3):e12575
- Cell Commun Signal, 2019 17(1):75
- Int J Biol Macromol, 2019 135:212-225
- Oncogene, 2019 38(49):7433-7446
- Stem Cell Res Ther, 2019 10(1):80
- Stem Cell Res Ther, 2019 10(1):350
- Biomed Pharmacother, 2019 116:109032
- Free Radic Biol Med, 2019 141:21-33
- Oxid Med Cell Longev, 2019 2019:4546975
- Phytother Res, 2019 33(8):2102-2117
- Antioxid Redox Signal, 2019 31(12):804-818
- Life Sci, 2019 235:116863
- Life Sci, 2019 229:1-12
- Commun Biol, 2019 2:359
- Nutrients, 2019 11(4)E782
- Inflammopharmacology, 2019 27(3):561-571
- Am J Chin Med, 2019 913-931
- J Cell Physiol, 2019 234(11):20779-20789
- J Cell Physiol, 2019 234(4):4504-4514
- Int Immunopharmacol, 2019 77:105955
- J Cell Physiol, 2019 234(6):8846-8861
- Mar Drugs, 2019 17(1)E36
- J Cell Mol Med, 2019 23(2):920-933
- Cancers (Basel), 2019 11(6)E840
- Front Microbiol, 2019
- Aging (Albany NY), 2019 11(22):10610-10625
- Cancers (Basel), 2019 11(1)E75
- Chem Biol Interact, 2019 310:108741
- Cell Signal, 2019 54:17-26
- J Biol Chem, 2019 294(18):7221-7230
- FASEB J, 2019
- J Biol Chem, 2019 294(9):3284-3293
- Biochim Biophys Acta Gene Regul Mech, 2019 1862(8):846-857
- Front Oncol, 2019 9:1244
- Molecules, 2019 24(6)
- Molecules, 2019 24(6)
- Sci Rep, 2019 9(1):840
- Lipids Health Dis, 2019 18(1):71
- Environ Toxicol, 2019 34(6):679-688
- Cell Cycle, 2019 18(21):2928-2938
- Oncol Rep, 2019 41(6):3292-3304
- Biosci Rep, 2019 39(11)
- J Cell Biochem, 2019 120(8):12500-12507
- J Clin Med, 2019 8(6)
- Toxicol Appl Pharmacol, 2019 362:59-66
- Acta Biochim Biophys Sin (Shanghai), 2019 51(10):1056-1063
- Exp Cell Res, 2019 379(1):65-72
- Biomed Res Int, 2019 2019:9612125
- Biomed Res Int, 2019 2019:3851718
- J Cancer Res Clin Oncol, 2019 145(2):411-427
- Am J Reprod Immunol, 2019 81(1):e13073
- Toxicol Lett, 2019 301:98-107
- Gene, 2019 683:195-209
- J Tissue Eng Regen Med, 2019 13(4):625-636
- Cancer Manag Res, 2019 11:839-855
- Free Radic Res, 2019 53(3):348-358
- Cancer Manag Res, 2019 11:2653-2661
- Alcohol Clin Exp Res, 2019 43(11):2344-2353
- Toxicol In Vitro, 2019 56:156-162
- Med Sci Monit, 2019 25:6491-6503
- Med Sci Monit, 2019 25:7666-7674
- Biochem Biophys Res Commun, 2019 10.1016/j.bbrc.2019.11.110
- J Recept Signal Transduct Res, 2019 39(2):175-186
- Clin Res Hepatol Gastroenterol, 2019 10.1016/j
- Cell Biochem Biophys, 2019 77(4):367-377
- Am J Transl Res, 2019 11(9):5824-5835
- Cell Reprogram, 2019 21(5):238-248
- J Exp Clin Cancer Res, 2018 37(1):115
- J Exp Clin Cancer Res, 2018 37(1):113
- J Exp Clin Cancer Res, 2018 17;37(1):8
- Genes Dev, 2018 32(5-6):448-461
- Sci Total Environ, 2018 643:496-506
- Cell Death Dis, 2018 9(12):1140
- Cell Death Dis, 2018 9(3):278
- Cell Death Dis, 2018 9(11):1052
- Br J Cancer, 2018 119(9):1094-1105
- Oncogene, 2018
- Oncogene, 2018 37(24):3275-3289
- Elife, 2018 7
- Biomed Pharmacother, 2018 105:320-325
- Biomed Pharmacother, 2018 105:282-289
- Oxid Med Cell Longev, 2018 2018:4572893
- Front Immunol, 2018 9:2033
- Mol Oncol, 2018 12(2):224-238
- J Agric Food Chem, 2018 66(31):8307-8318
- J Agric Food Chem, 2018 66(41):10721-10728
- Hum Reprod, 2018 33(11):2096-2106
- Inflammopharmacology, 2018 10.1007/s10787-018-0492-y
- J Virol, 2018 92(8)
- J Cell Mol Med, 2018 22(7):3340-3352
- Cancers (Basel), 2018 10(11)E439
- Biochim Biophys Acta Mol Cell Res, 2018 1865(1):57-66
- Biochim Biophys Acta Mol Cell Biol Lipids, 2018 1863(2):177-190
- Molecules, 2018
- Sci Rep, 2018 8(1-:10070
- Sci Rep, 2018 8(1):3120
- Toxicology, 2018 408:62-69
- Neurochem Res, 2018 43(10-:1963-1977
- Stem Cells Int, 2018 2018:9793845
- Oncol Rep, 2018 40(1):29-38
- Oncol Rep, 2018 40(2):775-782
- Chem Res Toxicol, 2018 31(2):127-136
- Tissue Eng Part A, 2018 24(5-6):502-515
- Cell Mol Neurobiol, 2018 38(3):627-633
- Front Physiol, 2018 9:765
- Cancer Med, 2018
- J Cell Biochem, 2018 119(1):300-313
- J Cancer, 2018 9(23):4449-4462
- Biochimie, 2018 152:43-52
- Cell Biol Int, 2018 42(5):598-607
- PLoS One, 2018 13(9):e0203402
- PLoS One, 2018 13(5):e0197422
- PLoS One, 2018 13(7):e0200878
- J Cancer Res Clin Oncol, 2018 144(8):1487-1501
- Cell Biochem Funct, 2018 36(3):155-165
- Ann Hematol, 2018 97(4):641-654
- Cell Adh Migr, 2018 12(2):109-117
- Biochem Biophys Res Commun, 2018 496(4):1291-1295
- Oncol Lett, 2018 15(5):7443-7449
- Oncol Lett, 2018 15(6):8442-8446
- In Vivo, 2018 32(3):549-554
- In Vivo, 2018 32(6):1361-1368
- Am J Transl Res, 2018 10(8):2555-2566
- Nat Commun, 2017 8:15776
- J Clin Invest, 2017 127(1):153-168
- Dev Cell, 2017 41(5):527-539.e5
- Cancer Lett, 2017 395:31-44
- Cancer Lett, 2017 401:1-10
- Anesthesiology, 2017 126(5):868-881
- Cell Prolif, 2017 50(1)
- Oncogene, 2017 36(46):6359-6373
- Biomed Pharmacother, 2017 89:1037-1044
- Biomed Pharmacother, 2017 87:332-341
- Mol Cell Proteomics, 2017 16(9):1694-1704
- PLoS Pathog, 2017 13(4):e1006321
- Antioxid Redox Signal, 2017 27(2):73-92
- Int J Mol Med, 2017 39(1):217-222
- Oncotarget, 2017 8(35):58417-58429
- Oncotarget, 2017 8(55):93878-93898
- Oncotarget, 2017 8(15):24237-24249
- Oncotarget, 2017 8(33):55084-55093
- Chem Biol Interact, 2017 270:1-8
- Endocrinology, 2017 158(10):3281-3291
- J Neurochem, 2017 142(2):231-245
- Sci Rep, 2017 7:43242
- Sci Rep, 2017 7(1):13319
- Sci Rep, 2017 7(1):1663
- Pflugers Arch, 2017 469(9):1061-1071
- Poult Sci, 2017 96(9):3043-3051
- Neurochem Res, 2017 10.1007/s11064-017-2174-3
- J Neurol Sci, 2017 372:171-177
- Cell Physiol Biochem, 2017 41(5):1957-1969
- Oncol Rep, 2017 37(2):1036-1044
- Oncol Rep, 2017 38(1):591-597
- J Steroid Biochem Mol Biol, 2017 171:318-327
- Onco Targets Ther, 2017 10:627-643
- Immunol Cell Biol, 2017 95(10):943-952
- Cell Biol Int, 2017 41(12):1307-1315
- Brain Res Bull, 2017 130:236-244
- Microb Pathog, 2017 10.1016/j.micpath
- Exp Cell Res, 2017 360(2):281-291
- PLoS One, 2017 12(12):e0189920
- Exp Dermatol, 2017 26(5):409-415
- Cell Biochem Funct, 2017 35(5):278-286
- Mol Med Rep, 2017 16(2):1445-1450
- Mol Med Rep, 2017 16(2):1417-1424
- Food Nutr Res, 2017 61(1):1368321
- DNA Cell Biol, 2017 36(11):1029-1038
- Biochem Biophys Res Commun, 2017 492(2):206-211
- Spine (Phila Pa 1976), 2017 42(2):E61-E70
- Dev Comp Immunol, 2017 76:392-402
- Evid Based Complement Alternat Med, 2017 2017:5985703
- Evid Based Complement Alternat Med, 2017 2017:4198486
- Menopause, 2017 24(4):437-451
- Am J Transl Res, 2017 9(6):2878-2890
- J Asthma, 2017 54(5):467-475
- Drug Discov Ther, 2017 11(4):212-217
- Clin Cancer Res, 2016 10.1158/1078-0432.CCR-15-2242
- Br J Dermatol, 2016 175(6):1221-1231
- Cell Death Dis, 2016 7(10):e2435
- Cell Death Dis, 2016 7(10):e2412
- J Transl Med, 2016 14:46
- Oxid Med Cell Longev, 2016 2016:2572175
- Inflamm Res, 2016 65(3):193-202
- Mol Oncol, 2016 10(6):775-88
- Int J Mol Med, 2016 38(4):1125-34
- J Ethnopharmacol, 2016 193:293-302
- Oncotarget, 2016 7(19):27874-88
- Oncotarget, 2016 7(28):43442-43460
- Oncotarget, 2016 7(30):48501-48516
- Oncotarget, 2016 7(16):22623-31
- Oncotarget, 2016 7(37):59236-59244
- Oncotarget, 2016
- Oncotarget, 2016 7(47):77749-77763
- Am J Cancer Res, 2016 6(2):509-21
- Stem Cells, 2016 34(11):2744-2757
- Neoplasia, 2016 18(7):425-35
- Sci Rep, 2016 6:30121
- Pflugers Arch, 2016 468(11-12):2041-2051
- Neurochem Res, 2016 41(7):1635-44
- Cell Physiol Biochem, 2016 39(4):1317-28
- Cell Immunol, 2016 310:63-70
- Int J Biochem Cell Biol, 2016 80:132-142
- Pharm Biol, 2016 54(10):2220-35
- Exp Cell Res, 2016 345(1):82-92
- PLoS One, 2016 11(1):e0146554
- Mol Med Rep, 2016 14(2):1430-8
- Exp Eye Res, 2016 145:456-467
- Biochem Biophys Res Commun, 2016 474(2):330-7
- Prostate, 2016 76(3):273-85
- Exp Ther Med, 2016 11(6):2413-2419
- Toxicol Res (Camb), 2016 5(6):1573-1584
- Tumour Biol, 2016 37(8):10257-67
- Tumour Biol, 2016 37(3):3727-38
- Nat Commun, 2015 6:8481
- Nat Commun, 2015 10.1038/ncomms9390
- Clin Cancer Res, 2015 21(19):4420-30
- J Transl Med, 2015 13(1):42
- Am J Cancer Res, 2015 5(9):2660-72
- Mol Nutr Food Res, 2015 59(12):2471-9
- Mol Cancer Res, 2015 13(12):1578-90
- J Nat Prod, 2015 78(7):1689-96
- Sci Rep, 2015 5:18314
- Neurochem Res, 2015 40(8):1609-19
- Arch Biochem Biophys, 2015 585:10-16
- Cytokine, 2015 71(2):139-44
- Acta Biochim Biophys Sin, 2015 47(7), 1–9
- PLoS One, 2015 10(4):e0122109
- Cell Biochem Funct, 2015 33(3):134-42
- Cancer Biol Ther, 2015 16(4):602-9
- Toxicol In Vitro, 2015 30(1 Pt B):521-8
- Exp Biol Med, 2015 10.1177/1535370215576312
- Biochem Biophys Res Commun, 2015 463(4):612-7
- Evid Based Complement Alternat Med, 2015 2015:307594
- J Orthop Res, 2015 10.1002/jor.22830
- Leuk Res, 2015 10.1016/j.leukres.2015.08.007
- Tissue Cell, 2015 47(3):301-10
- J Cardiovasc Pharmacol, 2015 66(3):285-93
- Growth Factors, 2015 33(5-6):356-65
- Genet Mol Res, 2015 14(4):18325-33
- EMBO Mol Med, 2014 6(6):821-34
- Cell Death Dis, 2014 5:e1428
- Cell Death Dis, 2014 5:e1187
- Biomed Pharmacother, 2014 68(8):1037-43
- Br J Pharmacol, 2014 171(24):5757-73
- Thromb Haemost, 2014 112(5):992-1001
- Life Sci, 2014 108(2):63-70
- Mol Cancer Ther, 2014 13(4):926-37
- FASEB J, 2014 10.1096/fj.13-247924
- Carcinogenesis, 2014 35(4):795-806
- Oncol Rep, 2014 32(6):2777-88
- Am J Physiol Renal Physiol, 2014 307(1):F75-85
- Chem Res Toxicol, 2014 27(9):1575-85
- PLoS One, 2014 9(3):e85705
- PLoS One, 2014 9(1):e87311
- PLoS One, 2014 9(5):e94753
- Toxicol Lett, 2014 226(1):81-9
- J Periodontal Res, 2014 10.1111/jre.12193
- Cell Microbiol, 2014 16(9):1441-55
- Biochem Biophys Res Commun, 2014 455(3-4):256-61
- Biochem Biophys Res Commun, 2014 446(1):167-72
- Oncol Lett, 2014 8(4):1739-1744
- J Cardiovasc Pharmacol, 2014 64(2):180-90
- Regul Pept, 2014 194-195:41-8
- Hepatology, 2013 59(4):1262-72
- J Thromb Haemost, 2013 12(3):395-408
- Cell Commun Signal, 2013 11:82
- Mol Cell Proteomics, 2013 12(10):2952-68
- Microbes Infect, 2013 15(2):105-14
- Mol Cancer Ther, 2013 13(1):37-48
- Biomolecules, 2013 3(3):351-368
- Cell Signal, 2013 26(3):512-20
- J Steroid Biochem Mol Biol, 2013 144PA:223-227
- Mol Cell Endocrinol, 2013 375(1-2):89-96
- PLoS One, 2013 8(12):e82610
- PLoS One, 2013 8(8): e70732
- PLoS One, 2013 8(2):e56735
- PLoS One, 2013 8(12):e85032
- PLoS One, 2013 8(5):e63890
- Biochem Biophys Res Commun, 2013 429(3-4):156-62
- Cancer Cell Biology, 2013 134(11):2560-71
- J Genet Syndr Gene Ther, 2013 4
- Genetic Syndromes & Gene Therapy, 2013 4:6
- J Natl Cancer Inst, 2012 104(21):1673-9
- Microbiol Immunol, 2012 56(11):782-8
- J Biomol Screen, 2012 17(6):813-21
- Sci Signal, 2011 4(192):ra62
- Int J Mol Med, 2011 28(1):115-9
- Atheroscler, 2011 218(2):486-92
- J Biol Chem, 2010 285(43):32824-33
化学信息&溶解度
分子量 | 267.28 |
分子式 | C16H13NO3 |
CAS号 | 167869-21-8 |
Smiles | COC1=CC=CC(=C1N)C2=CC(=O)C3=CC=CC=C3O2 |
储存条件(自收到货起) | |
建议分装储备液,避免反复冻融! |
|
体外溶解度 | 批次: |
DMSO : 46 mg/mL ( 172.1 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 53 mg/mL ( 198.29 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble DMSO : 28 mg/mL ( 104.75 mM; DMSO吸湿会降低化合物溶解度,请使用新开封DMSO) Water : Insoluble Ethanol : Insoluble |
体内溶解度 | 批次: |
现配现用,请按从左到右的顺序依次添加,澄清后再加入下一溶剂 | |
4%DMSO
30%PEG300
5%Tween80
61%ddH2O
浓度:1mg/ml
(3.74mM)
操作示例:以 1 mL 工作液为例,取40μL25mg/ml的澄清DMSO储备液加到300μL PEG300中,混合均匀使其澄清;向上述体系中加入50μLTween80,混合均匀使其澄清;然后继续加入610μL ddH2O定容至 1 mL。工作液请现配现用!
|
摩尔浓度计算器
质量(g)= 浓度(mol/L)* 体积(L)* 分子量(g/mol)
动物体内配方计算器(澄清溶液)
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量)
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系Selleck为您提供正确的澄清溶液配方)
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,注:如该浓度超过该批次药物DMSO溶解度,请先联系Selleck);
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入 μL Tween 80,混匀澄清后加入 μL ddH2O,混匀澄清。
体内配方配制方法:取 μL DMSO母液,加入 μL Corn oil,混匀澄清。
注意:
1. 首先保证母液是澄清的;
2.一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。